Table 4. CD4 counts and HIV-RNA levels at EOT and 12 weeks after EOT from fitting an analysis of covariance model controlling for baseline values, according to use of ribavirin (RBV).

HIV lab markers	RBV in DAA	RBV-free DAA		RBV in DAA	RBV-free DAA
	Unadjusted Mean (95% CI)		p-value	Adjusted Mean (95% CI)		p-value
CD4 count at EOT
cells/mm3	481 (454, 507)	616 (588, 644)	< .001	480 (453, 507)	616 (588, 644)	< .001
CD4 count 12 weeks after EOT
cells/mm3	623 (589, 656)	663 (628, 699)	0.1	624 (590, 657)	665 (629, 700)	0.1
HIV-RNA at EOT
log10 copies/mL	0.5 (0.4, 0.6)	0.7 (0.5, 0.8)	0.07	0.5 (0.4, 0.6)	0.7 (0.6, 0.8)	0.03
HIV-RNA 12 weeks after EOT
log10 copies/mL	0.6 (0.4, 0.7)	0.6 (0.5, 0.8)	0.4	1.0 (0.4, 0.7)	0.6 (0.5, 0.8)	0.4

Adjusted mean: adjusted for gender, age, HCV genotype, decompensate cirrhosis and diabetes.

HIV-RNA also adjusted for CD4 count at DAA initiation and vice versa.